Simmons, D. A., James, M. L., Belichenko, N. P., Semaan, S., Condon, C., Kuan, J., . . . Longo, F. M. (2018). TSPO–PET imaging using [(18)F]PBR06 is a potential translatable biomarker for treatment response in Huntington’s disease: Preclinical evidence with the p75(NTR) ligand LM11A-31. Hum Mol Genet.
Citação norma ChicagoSimmons, Danielle A., et al. "TSPO–PET Imaging Using [(18)F]PBR06 Is a Potential Translatable Biomarker for Treatment Response in Huntington’s Disease: Preclinical Evidence With the P75(NTR) Ligand LM11A-31." Hum Mol Genet 2018.
Citação norma MLASimmons, Danielle A., et al. "TSPO–PET Imaging Using [(18)F]PBR06 Is a Potential Translatable Biomarker for Treatment Response in Huntington’s Disease: Preclinical Evidence With the P75(NTR) Ligand LM11A-31." Hum Mol Genet 2018.